Parameter | Values |
---|---|
N | 37 |
Age (years) | 55.2 ± 12.9 |
Female (n, %) | 36 (97.3%) |
Disease duration (years) | 9 (0.5–42) |
Skin ulcers (n, %) | 12 (32.4%) |
ESR (mm/h) | 22.6 ± 18 |
Total cholesterol (mg/dL) | 195 ± 41 |
Creatinine (mg/dL) | 0.79 ± 0.25 |
ANA + (n, %) | 33 (89.1%) |
Anti-Scl-70 + (n, %) | 13 (35.1%) |
ACA + (n, %) | 16 (43.2) |
Type of the disease (n, %) | |
Diffuse | 13 (35.2%) |
Limited | 24 (64.8%) |
PAH | 8 (21.6%) |
Interstitial lung fibrosis (n, %) | 14 (37.8%) |
NVC patterns (n, %) | |
Early | 11 (29.7%) |
Active | 10 (27.0%) |
Late | 16 (43.2%) |
CSURI | 4.2 (0.63–34.6) |
cIMT (mm) | |
Right | 0.74 ± 0.14 |
Left | 0.68 (0.52–1.16) |
PWV (m/s) | 7.2 (4.8–18.5) |
AIx (%) | 30.2 ± 11.6 |
CSBP (mmHg) | 121 ± 20 |
SBP (mmHg) | 131 ± 21 |
DBP (mmHg) | 76 ± 10 |
Calcium channel blockers (n, %) | 19 (51.4) |
Vasodilators | |
ERAs (n, %) | 10 (27%) |
PDEi (n, %) | 2 (5.4%) |